when was semaglutide patented Last week's expiry of the patent for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Massive Rs 50,000 Cr Opportunity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21







![Wegovy Lawsuit [2026 Update]](https://trulaw.com/wp-content/uploads/2024/02/Wegovy-Lawsuit_-Gastroparesis-And-Pancreatitis-Claims.png)











